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Greetings and welcome to our special issue dedicated to the study of infectious diseases. This subject is especially near and dear to my heart since, a long time ago in a galaxy far far away, I studied microbiology prior to becoming a physician --and, shockingly, I continue to put this undergraduate degree to use some 40 years later. You may notice two of the articles in this issue wholly or partly deal with the environmentally acquired fungal disease blastomycosis. 1, 2 While not claiming to be an expert, this disease and the organisms involved have kept me fascinated and engaged for more than 25 years.
Blastomycosis was first described in the late 1800s, with a high proportion of recognized cases confined to the skin. 3 We now recognize that almost all cases occur following inhalation of conidia (spores) from the environmental source into the lungs. The pulmonary infection that may follow is often asymptomatic, but can range from mild to severe to life-threatening. The fungus may disseminate from the lungs and cause disease in a variety of organs and tissues, including the skin. 4 The etiologic agents of blastomycosis are now considered members of one of two species, Blastomyces dermatitidis or Blastomyces gilchristii. 5 But at least two central mysteries pertaining to Blastomyces persist.
One of the mysteries, as discussed in this issue by Huber et al., is that the particular environmental niche of Blastomyces, if there is a specific one, is still being elucidated. 1 These organisms are dimorphic microscopic fungi. What does that mean? Simply put, they are microbial "switch-hitters" that grow as a mold at normal environmental temperatures, then undergo a complex phase transition and grow as a broad-based, budding yeast at body temperature (and under certain other conditions).
4,6-8
The second mystery yet to be solved is exactly why these organisms evolved this dimorphic ability and devote so much genetic and cellular machinery to the phase transition. Clearly, a transition to yeast at body temperature allows the fungus to successfully infect and propagate within a mammal --outside of the laboratory, this occurs predominantly in dogs, humans and an occasional domesticated cat. The resultant yeast cell is too large to be ingested by polymorphonuclear neutrophils (PMNs), unlike the smaller infectious conidia particles (spores). The yeast is also less readily killed by PMNs and peripheral blood monocytes. 6 Recent experiments in mice suggest that ingestion of spores by alveolar macrophages, conversion of the spores to yeast and a transient intracellular residence in these macrophages may be important for early successful pulmonary infection.
JPCRR • Volume 3, Issue 2 • Spring 2016
Editorial host carcasses within soil rather than the soil itself, 10 the contribution of mammalian host carcasses in the natural environment to propagation of Blastomyces is unknown. No significant animal natural host or vector has yet been identified. 11 This differs from a related dimorphic fungus, Paracoccidioides brasiliensis, which has been shown to have a natural mammalian host, the armadillo, that may have afforded a long coexistence with the fungus. 12 Bagagli et al. hypothesized that parasitism (yeast-form colonization/ infection of a warm-blooded animal) helps the Paracoccidioides fungus "find shelter, food and opportunities for multiplication and dispersal," thereby increasing the opportunity for sexual reproduction to minimize genetic weakness. 12 It is certainly conceivable that Blastomyces could be spread to the natural environment from a person or animal with fulminating pulmonary blastomycosis via expectorated sputum or saliva containing significant yeast forms of the organism. 13 Saliva, in fact, may help protect yeast-phase Blastomyces from lysis by bacteria on natural substances.
14 Blastomyces also has been identified in mammalian stool, including human, 15 dog 16 and, via experimental oral inoculation, bat.
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Neither Blastomyces nor a related dimorphic fungus, Histoplasma capsulatum, have been isolated from the cloaca of birds; however, the latter has been strongly associated with bird guano. 18 Could temporary or more permanent colonization of the gastrointestinal tract of a known host or a previously unrecognized associated animal be common enough to qualify as important for the dispersal of Blastomyces? The transient passage of fungal forms in feces of those animals with fulminating pulmonary infection would presumably be rare, but perhaps frequent enough for effective dispersal, especially in centuries prior to modern sanitation (Blastomyces and relatives likely date back several million years 12 ). Could inadvertent swallowing of mold forms of the fungus and colonic passage of mold or yeast forms by animals that feed or peck among soil offer a more common form of dispersal? Blastomyces strains have been shown to grow in vitro when exposed to ammonia levels up to 42-62 mmol/l in the mold form 19 and at least 21 mmol/l in the yeast form (Dennis Baumgardner, unpublished observations). This may be critical, given elevated ammonia concentrations in excreta of birds, 20 the large intestine of rodents 21 and human colons in which levels up to 60-70 mmol/l may be transiently reached. 22 As we have previously discussed, 23 at least one Blastomyces strain (ER-3/ATCC MYA 2586) appears to be nonpathogenic in the laboratory (Bruce Klein, personal communication; and as reported by the Broad Institute 24 ). However, this strain readily converts to the yeast form at 37°C on standard media and, to some extent, at room temperature under certain nutritional conditions. 8 If there are indeed strains that are inherently nonpathogenic in the environment, it makes the mystery even more intriguing --for example, the purpose could be to colonize (if even transiently), but not infect, mammalian surfaces or the gastrointestinal tract for purposes of dispersal. This possibility was investigated in two groups of animals that yielded negative results. Cultures of the intestinal tracts of 60 shrews and 5 small rodents as well as rectal cultures from several beavers failed to grow Blastomyces. 11, 25 Perhaps thermal dimorphism was critical millions of years ago when warm water environments were frequently encountered and the yeast form afforded some sort of advantage over conidia for water dispersion. We simply do not know.
How then did strains of Blastomyces become pathogenic for animals in the first place? As proposed by Casadevall and colleagues [26] [27] [28] and reiterated by Bagagli et al., 12 virulence factors of soil-dwelling fungi may have evolved to ward off destruction by nematodes or amoebae, and may have already been in place to survive in mammalian hosts once appropriate mammals evolved. Whereas most of these organisms are restricted from infection by the higher mammalian body temperature, 28 not so when it comes to dimorphic fungi.
All things considered, it seems plausible that Blastomyces evolved thermal dimorphism for a necessary, but more benign, purpose than infecting and potentially killing us or our companion animals.
Finally, it is no secret we at the Journal of PatientCentered Research and Reviews pride ourselves on publishing patient-based content. Heck, it's right there in our name. So you may be wondering what possible benefit this intellectual discourse adds to the care of the patient. As one who has spoken to scores of patients with blastomycosis and their family members, I will testify that people want to know "where this disease comes from," including details of why it lives in a certain environment and how it gets into people. Perhaps this editorial will inform these discussions. Ultimately, further research into the whys and hows of blastomycosis pathogenesis may lead to improved treatment.
Besides, isn't science fun?
